# AI Denials Management Buyer's Guide

**Date:** July 30, 2025  
**Author:** Patrick Wingo, Director of Research, Elion

**Categories:** Denials Management

---

Colin DuRant

Head of Research, Elion

# **Executive Summary**

This guide provides a practical framework for evaluating [AI-enabled denials management solutions](https://elion.health/categories/ai-denials-management/products), a fast-evolving category within healthcare revenue cycle management. As denial rates rise and staffing constraints persist, health systems are reexamining how automation, machine learning, and generative AI can improve both denial prevention and appeals workflows.

Inside, you’ll find:

- A breakdown of the core denials workflow, from claim submission to resolution

- Specific ways AI tools are being applied across denial ingestion, triage, appeals, and monitoring

- A market overview that segments vendors by functionality and buyer priority

- A detailed evaluation checklist to help teams assess fit, functionality, and ROI

This guide is built for provider revenue cycle, finance, and IT leaders navigating solution selection, pilot scoping, or general market education. Use it to clarify whether and how modern AI tools can help reduce avoidable write-offs, streamline appeals, and improve recovery performance.

# **Why AI Denials Management Solutions Are Worth Considering Now**

Denials have become one of the most urgent and costly challenges in revenue cycle management. Escalating rejection rates and mounting pressure on provider margins have turned denials management into a frontline issue. Fortunately, the advent of advanced technologies capable of addressing denials from the provider side may soon make the playing field more even.

It’s difficult to get independently verifiable statistics around the rising number of denials, but according to a 2024 “State of Claims” [survey](https://www.experian.com/healthcare/resources-insights/thought-leadership/white-papers-insights/state-claims-report) of provider billing staff by [Experian](https://elion.health/products/experian-denial-management), 49% say claims are denied 10-15% of the time or more, and one recent industry [report](https://premierinc.com/newsroom/policy/claims-adjudication-costs-providers-257-billion-18-billion-is-potentially-unnecessary-expense) estimated that nearly $18 billion was spent annually on processing denials that were ultimately overturned. And the reasons for denials are myriad. As illustrated in the chart below, which is based on denials and appeals [data](https://www.kff.org/private-insurance/issue-brief/claims-denials-and-appeals-in-aca-marketplace-plans-in-2023/) from ACA Marketplace plans, claims can be denied for both clinical reasons as well as administrative, plus a large long-tail of “other reasons” that can often be difficult to decode.

As a backdrop, health systems face mounting financial and staffing challenges. Hospital operating margins [have remained low](https://www.beckershospitalreview.com/finance/hospital-operating-margins-to-stay-low-in-2025-moodys/) in recent years, making every dollar of potentially recoverable revenue vital. Meanwhile, revenue cycle departments are grappling with staffing shortages and high turnover, leading to growing backlogs of unworked denials. Many organizations know more denied claims could be recovered with proper follow-up, but they simply lack the workforce capacity to pursue every denial.

While the precise impact of denials will vary across organization type, specialty, and payer mix, providers almost universally agree that aggressive payer tactics have significantly increased denial rates. Increasingly, payers are deploying AI-driven systems to review claims post-service, rapidly applying complex rule sets and algorithms to flag potential denial reasons—often under the broader umbrella of [utilization management](https://en.wikipedia.org/wiki/Utilization_management), though these actions may occur well after care is delivered.

The conditions are ripe for a technological [arms race](https://fellowhealthpartners.com/denial-rates-surge-how-the-ai-arms-race-in-insurance-is-impacting-patients-and-providers) between payers and providers. The embrace of automation and algorithmic decision-making amongst payers has led healthcare provider organizations to seek their own AI solutions in response. The good news for providers: The technology stack for handling denials has fundamentally changed over the last several years in a couple key ways:

First, while not unique to denials management, the maturation of interoperability has played a critical enabling role in establishing the infrastructure required for automation across the revenue cycle. Provider organizations now have access to standardized APIs, robust data pipelines, and cloud infrastructure that can handle massive document processing loads.

Second, and more transformationally, modern AI excels at the exact types of tasks that make denials management so burdensome:

- **Large language models (LLMs)** can generate detailed, evidence-backed appeal letters in seconds.

- **Agentic solutions** can perform tasks like checking claim statuses or submitting appeal packets by navigating payer portals.

- **Machine learning** can now detect subtle shifts in payer behavior, such as changes in denial patterns, before official policy updates are even released, giving providers a proactive edge.

In essence, the "why now" is a perfect storm of painful financial losses, a strained workforce, aggressive payer behavior, and a maturation of interoperability and AI/ML capabilities.

## **Defining Denials Terminology**

Before diving into the specifics of AI denials management, it’s worth defining key terms and outlining the denials workflow more clearly.

- **Rejection**: A rejection occurs at an earlier stage in the claims process than a denial, typically within 72 hours of submission. Rejections happen prior to a claim's acceptance by the payer and are not assigned a claim identifier in the payer's system. These claims fail initial validation checks and never enter the adjudication process for reasons such as misspelled patient information or formatting issues.

- **Denial**: A denial occurs when a health insurance company refuses to pay for a service or procedure. Denied claims have been adjudicated by the payer and ultimately result in non-payment or underpayment.

  - **Soft Denial**: A denial that successfully passes initial, basic validation checks, but issues are discovered during adjudication, such as invalid coding, missing modifiers or eligibility issues. Soft denials do not result in a rejection and can often be resolved by providing the missing or corrected information without going through the appeals process.

  - **Hard Denial**: A denial that cannot be corrected and resubmitted; typically an appeal is required to try to overturn the decision. These often result in lost revenue or write-offs, as the provider is generally unable to recover payment. Common reasons include non-covered services, contract exclusions, or lack of timely filing.

- **Prior Authorization Denial:** Not a denial in the true sense, a prior authorization (PA) denial occurs when a health insurance company refuses to pre-approve a medical procedure or drug that a patient and doctor have requested. If prior authorization is denied, the patient will not get the requested care; if they do and a claim still gets submitted, it will lead to a hard denial. ( [Broader discourse](https://www.ama-assn.org/practice-management/prior-authorization/how-ai-leading-more-prior-authorization-denials) around payers denying care frequently refers to PA denials as opposed claim denials, leading to some confusion regarding denials and denial rates amongst the media and policymakers.)

- **DRG Downgrade:** A post‑payment or concurrent‐audit action in which the payer reassigns an inpatient stay to a lower‑weighted diagnosis related group (DRG), thereby lowering the reimbursement without fully denying the claim. Downgrades often cite missing clinical validation or coding or documentation gaps that remove a Complication or Comorbidity/Major Complication or Comorbidity (CC/MCC). Hospitals can appeal by supplying documentation that supports the higher‑severity DRG and citing official coding guidelines.

- **Clinical Appeal:** An evidence‑based challenge to a hard denial issued for medical‑necessity, level‑of‑care, or coverage reasons. The appeal package typically contains a physician narrative, peer‑reviewed guidelines, and record excerpts showing the service met accepted clinical criteria. It may progress through internal medical‑director review, peer‑to‑peer discussion, and (if upheld) external review.

- **Technical Appeal:** A provider request for the payer to reverse a soft denial triggered by an administrative misstep (demographic error, missing modifier, late filing flag, etc.). The appeal is decided solely on whether the corrected paperwork now meets the payer’s edits and rarely needs physician input.

- **Peer-to-Peer Discussion:** A structured conversation between a treating clinician and a payer’s medical director or reviewer, aimed at directly addressing clinical denials, such as those based on medical necessity, level-of-care, or clinical validation. These discussions allow providers to clarify clinical decision-making, supply context absent from initial documentation, and reference evidence-based guidelines. While successful peer-to-peers can efficiently resolve complex denials without proceeding to formal appeals, they are resource-intensive, often requiring valuable physician or advisor time away from patient care or other critical activities.

# **Denials Management Workflow and Opportunities**

Denials management remains manual and fragmented for most providers, with many organizations lacking the capacity to work every denial. High-value appeals require time and coordination, while lower-value denials are often written off. Complex payer processes—like navigating portals, locating policy documentation hidden in PDFs or siloed systems, and assembling appeal packets—add friction at every step.

Just as importantly, most workflows lack mechanisms to capture and reuse insights. Denials related to prior authorization, medical necessity, or documentation gaps often signal upstream issues, but without structured feedback loops, the same avoidable denials repeat.

## **Current Denials Management Workflow**

Denials management is a complex, multi-step workflow, with core responsibilities anchored in the revenue cycle management (RCM) team and supported by clinical documentation improvement (CDI) and revenue integrity teams. While the work is distributed, denials specialists within RCM typically carry the day-to-day operational load.

The process starts when a denial is received. Specialists interpret the denial codes and triage them into the appropriate work queues—prioritized primarily by claim value but also by factors like denial type, payer, and filing deadlines. Teams then work the queue denial by denial, with volume often outpacing capacity.

**Soft denials**, typically caused by administrative issues like incorrect patient insurance details or missing billing codes, are usually straightforward to fix and quickly resubmitted.

**Hard denials**, on the other hand, trigger a multi-step appeals process. This includes:

- Investigating the root cause beyond the code (e.g., clinical mismatch, lack of prior auth).

- Gathering supporting documentation from patient records and payer policy databases.

- Drafting customized appeal letters tailored specifically to each payer’s requirements.

- Submitting appeals via payer portals, fax, or mail.

- Tracking deadlines, following up persistently, and managing rework from secondary denials.

In parallel, effective teams conduct denials trend analysis to spot patterns and implement systemic fixes like revising documentation templates, updating coding protocols, or training clinical staff on documentation pitfalls. But these upstream interventions often lose out to the day-to-day grind of reactive appeals. Even when process changes are made, it’s a moving target. Payers regularly update policies, contracts shift, and billing codes evolve—making it feel like you’re always chasing the next fire. Many leaders describe it as an endless loop: Progress is possible, but lasting control remains just out of reach.

## **AI in the Denials Management Workflow**

### **Claim Submission: Shifting from Reactive Corrections to Proactive Prevention**

Traditionally, preventing denials at the point of claim submission meant relying on manual checks and rules-based scrubbers, tools built to catch formatting issues and basic coding errors. But those systems had blind spots. Coding and billing teams often didn’t have access to real-time payer policy updates or insight into which procedures were most likely to be denied. As a result, many issues slipped through, only to be caught after submission.

That’s changing. Today’s [AI-driven denials management](https://elion.health/categories/ai-denials-management/products) tools embed directly into EHR and RCM workflows, applying real-time payer rules and predictive analytics before the claim goes out the door. These systems flag high-risk encounters, alert teams to documentation gaps, and suggest changes early, helping prevent avoidable denials upfront.

Unlike static rules engines, AI-powered platforms continuously learn from recent denials, policy changes, and historical trends. They adapt in real time, surfacing new patterns and payer-specific nuances that older tools miss. This continuous feedback loop means smarter, more compliant submissions without adding more manual work.

### **Denial Intake: Turning Remittance Data into Actionable Insights**

Processing payer responses, especially electronic data interchange (EDI) 835 remittance files and EDI 277 claim status updates, can be time-consuming and opaque. Decoding cryptic CARC and RARC code combinations often slows down categorization and delays next steps.

## Defining Denials Terminology

- **Claim Adjustment Reasoning Code (CARC):** A standardized code [set](https://x12.org/codes/claim-adjustment-reason-codes) in the 835 electronic remittance advice (ERA) that explains _why_ the payer paid less than the billed amount (e.g., “97 – Payment is included in the allowance for another service”). Teams use CARCs to parse denial categories and to determine appropriate next steps.

- **Remittance Advice Remark Codes (RARC):** Another standardized code [set](https://x12.org/codes/remittance-advice-remark-codes) in the 835/ERA. Most RARC codes provide supplemental contextual detail about the adjustment beyond what’s in the CARC (e.g., “N422 – Missing documentation”).

Modern AI-driven solutions streamline this process by automatically ingesting and normalizing remittance data. They interpret denial codes in context and flag underpayments by comparing allowed amounts to contract terms—all in near real-time. This automation transforms raw data into clear, actionable insights the moment a denial arrives.

While most payer responses flow through standard EDI, not everything is digitized. Some denials or appeal-related information still comes in via fax or physical mail. To handle this, some platforms integrate with enterprise content management tools to pull in digitized documents automatically. Others may require manual upload of scanned PDFs.

### **Root-Cause Analysis and Triage: Intelligent Prioritization for Optimal Impact**

Once a denial is received, two key steps typically follow in the traditional workflow:

1. **Root cause analysis** to determine why the claim was denied—going beyond the high-level CARC and RARC codes. For instance, a “medical necessity” denial could stem from missing clinical documentation, an outdated payer policy, or incorrect coding. Each cause requires a different fix.

2. **Triage and prioritization**, often based on the dollar value of the claim. While factors like filing deadlines and denial type matter as well, dollar amount tends to carry the most weight, especially in resource-constrained environments.

Modern AI-driven tools bring more precision to both steps:

- **For root cause analysis**, leading platforms synthesize data from across the claim lifecycle (837/835 data, prior auth records, and medical documentation) then match it against historical payer behavior. The result: a clear, confidence-weighted explanation of what went wrong, where it happened, how to fix it, and how to prevent recurrence.

- **For triage**, AI models score each denial based on expected financial recovery, likelihood of overturn, and filing deadlines. These systems use contract terms, historical appeal outcomes, and time sensitivity to continually update work queues, surfacing high-value, time-critical cases first. Simpler issues with high addressability confidence may be automatically corrected and resubmitted without manual intervention.

By replacing rough heuristics with intelligent scoring, AI tools can help teams focus where it counts, improving both efficiency and appeal success rates.

### **Evidence Collection and Appeal Assembly: AI-Enhanced Efficiency**

Building a complete, payer-compliant appeal packet is one of the most time-consuming parts of the denials process. Without AI, staff must manually examine the reasons for the denial, pull clinical documentation, match it to the appropriate payer policies, write the appeal letter, and ensure the packet meets varying requirements across different payers. Just staying current with policy changes is a major lift—so much so that vendors like [Policy Reporter](https://www.policyreporter.com/) and [Policy Bot](https://www.policybot.app/About) now license payer policy libraries to [denials management platforms](https://elion.health/categories/ai-denials-management/products) to support more accurate, efficient appeals.

AI-enabled solutions streamline this entire process through:

- **Medical record aggregation**: These platforms automatically extract relevant portions of the clinical documentation needed to support the appeal.

- **Payer policy alignment**: By integrating with up-to-date payer policy libraries, they ensure the appeal is grounded in the correct coverage criteria.

- **Appeal letter generation**: Using generative AI, the system drafts physician-quality narratives tailored to the denial reason and payer-specific requirements.

- **Packet assembly**: The platform then compiles the full appeal in line with each payer’s specific submission standards including documentation, references, and formatting.

This approach not only saves time but also raises the bar on consistency and compliance.

### **Appeal Submission: Automatically Navigating Payer Portals**

Even after an appeal packet is perfectly assembled, getting it submitted is often where things grind to a halt. Billing teams must manually log into a variety of payer portals, each with its own layout, quirks, and submission requirements. Staff upload documents one at a time, enter redundant metadata, and often have to confirm receipt via separate channels. It’s a slow, error-prone process that eats into already-stretched RCM resources.

Modern AI-powered platforms:

- **Automatically log in** to payer portals and navigate the submission process, just like a human user, but faster and without fatigue.

- **Upload complete packets** in the correct order and format, tagging them with the necessary metadata to ensure proper routing.

- **Confirm receipt** and extract submission IDs or confirmation messages, creating a verifiable audit trail for follow-up.

- **Schedule physician escalations** if required, prompting real-time coordination for peer-to-peer reviews or additional documentation needs.

Where payers offer APIs, these systems use direct integrations for even greater reliability and speed. And when APIs aren’t available, robotic process automation (RPA) fills the gap, handling tasks like portal navigation and document upload with minimal manual oversight.

This automation reduces turnaround time, lowers the risk of clerical error, and allows billing teams to spend more time managing high-impact cases rather than wrestling with login screens.

### **Monitoring and Escalation: Continuous Appeal Status Visibility**

Tracking the status of submitted appeals is one of the most repetitive and critical tasks in denials management, because payers don’t proactively communicate status changes or additional requirements. In traditional workflows, this process often falls to billing or follow-up staff, who must manually check payer portals, sift through spreadsheets or work queues, and make phone calls to verify whether appeals have been received, are under review, or require further action.

This manual tracking is time-consuming, error-prone, and frequently leads to missed deadlines, especially when payer systems don’t update in real time or status information is buried behind multiple logins. In high-volume environments, appeals can easily fall through the cracks, risking lost revenue despite initial recovery efforts.

Modern AI-enabled platforms now automate much of this follow-up. These tools:

- **Continuously poll payer portals and claim status APIs**, alerting staff when a denial status changes or a new action is required.

- **Track appeal deadlines and response SLAs** to ensure cases escalate before timing out.

- **Integrate with internal work queues** so that follow-up tasks are assigned proactively, not reactively.

Still, not all payers offer reliable digital status checks. Many continue to rely on phone calls as the only way to verify appeal status. Here, voice AI agents are emerging as a powerful tool:

- They handle the repetitive parts of the call, such as navigating phone trees, waiting on hold, and initiating basic inquiries.

- Some solutions transfer to a human when a live rep joins; others are beginning to engage in limited verbal dialogue directly with payer representatives.

Whether web-based or phone-based, automating this follow-up process helps ensure timely escalation, reduces administrative burden, and minimizes revenue leakage due to missed deadlines or untracked appeals.

### **Resolution and Continuous Learning: Closing the Feedback Loop**

In many organizations, the denials workflow effectively ends once a claim is resolved—whether paid, written off, or exhausted through appeals. What’s often missing is a structured feedback loop. The insights gained from successful (or failed) appeals rarely make it back to coding teams, documentation workflows, or claim scrubbing logic. As a result, the same issues recur, and opportunities to prevent future denials are lost.

AI platforms can help close this loop by systematically capturing and analyzing the outcomes of every appeal. These results are fed back into the broader system to:

- **Refine denial prediction models**, improving how potential denials are flagged pre-submission.

- **Recalibrate triage scoring**, adjusting appeal prioritization based on historical success rates.

- **Improve root cause attribution**, learning from real-world resolution patterns to sharpen upstream prevention.

This continuous learning capability means the system gets smarter with every resolved denial, helping teams shift from reactive management to true strategic improvement over time.

### **Full Appeal Automation and Performance Reporting**

Beyond streamlining individual workflow steps, AI-enabled denials platforms support two broader capabilities that unlock operational and strategic value for revenue cycle teams.

1. **Full Automation of Routine Cases**:Many platforms now support end-to-end automation for basic denials, particularly soft denials or simple clinical appeals where the root cause is clear and documentation is easily pulled. These tools can correct errors, generate appeal letters, and submit them without human intervention. This not only frees up staff to focus on complex or high-dollar cases, but also enables organizations to go after previously unworked low-value denials that were historically written off due to poor ROI. With automation, even those “not worth chasing” claims can now be recovered at scale.

2. **Strategic Performance Reporting and Contracting Intelligence**: In contrast to the dynamic feedback loops described earlier, where outcomes feed back into models to improve automation, these platforms also offer robust human-facing analytics. Dashboards break down denial trends by payer, provider, procedure, or denial reason. Some go further, offering machine learning-powered insights into emerging patterns, outlier behavior, or shifts in payer tactics.

These tools aren’t just for operational tuning; they’re built to support strategic decisions. Leaders can use them to inform payer negotiations, spot systemic issues like documentation gaps or coding inconsistencies, and guide resourcing across teams. While automation improves individual workflows, these analytics help drive broader business decisions across the organization.

# **Market Landscape**

[Denials management solutions](https://elion.health/categories/ai-denials-management/products) don’t fall into tidy boxes: many tools overlap across capabilities. A platform focused on appeals automation might also offer denial prediction; an analytics tool may integrate with appeal workflows. But buyers often have one problem they’re focused on solving first.

To create a usable framework, we analyzed the landscape based on the initial outcome buyers prioritize when selecting a solution. That might mean preventing avoidable denials, surfacing underlying patterns, clearing out a backlog, automating routine follow-up, consolidating revenue operations, or simply activating functionality already embedded in their EHR. We’ve grouped the market accordingly by the specific function buyers typically hire each category of solution to do.

## **Denials Prevention**

If your initial denial rate [exceeds](https://www.caqh.org/hubfs/43908627/drupal/2023-05/CORE%20-%20HC%20Claims%20Issue%20Brief%20Final.pdf) the national average of 12%, denials prevention solutions might be the right starting point. These solutions embed directly within EHR coding workflows, like traditional coding-enablement tools, but layer on machine learning models and real-time edits specifically designed to flag claims at high risk of denial.

Two critical capabilities distinguish denials prevention solutions from conventional coding-enablement solutions:

1. **Real-time feedback loops**: Instead of relying solely on static payer rules, these systems learn from historical claim outcomes to dynamically adapt guidance, surfacing denial risks that basic edits might miss.

2. **Denial-risk scoring**: Every claim is assigned a likelihood of denial, giving coding teams a clear signal of where to intervene before the claim goes out the door.

The primary advantage of investing in denials prevention is achieving a robust, sustainable reduction in denial rates over the long term. The trade-off, however, is that these solutions typically offer minimal immediate relief for teams currently handling denials, as the full benefits accumulate gradually downstream.

**Products in this category include:** [Anomaly](https://elion.health/products/anomaly), [Charta Health](https://elion.health/products/charta-health), [FinThrive Fusion](https://elion.health/products/finthrive-fusion/), [MDAudit](https://elion.health/products/mdaudit-revenue-integrity-suite), [RapidClaims RapidScrub](https://elion.health/products/rapidclaims-rapidscrub), [Sift Denials](https://elion.health/products/sift-denials).

## **Analytics and Payer Intelligence**

Analytics and payer intelligence is ideal when you require comprehensive revenue intelligence before addressing denials head-on. These solutions ingest raw claim files, often spanning multiple years, normalize the denial codes, apply proprietary payer-policy data, and deliver actionable dashboards at the payer, procedure, or even individual provider level. Most platforms update daily or even in real-time as streams of data arrive, allowing revenue leaders to both understand their day-to-day operations and see how trends have changed over time.

Unlike general revenue intelligence tools, they not only offer visibility into denial causes but also integrate the insights into the claims workflow. This enables proactive denial prevention during claim generation or enhances the appeal process by providing targeted, evidence-based documentation to maximize appeal success.

An example loop might be:

- Analytics detect that one major commercial payer denies ~20% of claims for a specific orthopedic surgery CPT when operative notes lack proof of prior conservative therapy.

- A real-time rule now fires at claim creation: If that CPT is selected, the coder is prompted to attach relevant progress notes and a templated sentence is inserted into the report.

- If a denial for “insufficient medical necessity” still occurs, the platform automatically assembles an appeal packet, pulling the full notes and imaging and quoting the payer’s published policy.

- The ready-to-file letter is pushed into the follow-up queue with a high-confidence overturn flag and a deadline set three days before the contractual limit.

- Appeal outcome data feeds back into the model, continuously sharpening both the preventive rule and the auto-appeal template.

**Products in this category include:** [Adonis Intelligence](https://elion.health/products/adonis-intelligence), [Anomaly](https://elion.health/products/anomaly), [MDClarity RevFind](https://elion.health/products/mdclarity-revfind), [Rivet Payer Performance](https://elion.health/products/rivet-payer-performance).

## **Appeals Automation Platforms**

For teams looking to scale their appeals operations, whether to work through routine denials faster or to handle complex cases more consistently, appeals automation platforms are a key category to consider. These solutions mirror the existing end-to-end appeals workflow, using AI and automation to reduce manual lift while improving quality and speed.

Most platforms offer a combination of these capabilities:

- 835 and EOB parsing to classify denials and identify appealable cases

- Automated retrieval of clinical documentation from the EHR

- Generative AI for appeal letter drafting, tailored to denial reasons and payer requirements

- RPA-based submission tools that can navigate diverse payer portals

Some solutions focus on high-volume, low-risk appeals, enabling full automation with minimal human touch. Others prioritize complex or clinical denials, using AI to generate highly customized, evidence-based appeal narratives that standardize and strengthen the response across staff.

Additional features like denial prediction or payer-specific analytics are often included but are not the primary reason buyers adopt these platforms. Because each vendor varies in focus (routine vs. complex, inpatient vs. outpatient, integration depth), selection should be guided by your organization’s denial mix, staffing model, and appeal intensity.

**Products in this category include:** [Arrow](https://elion.health/products/arrow), [Cofactor AI](https://elion.health/products/cofactor-ai-denials-suite), [Crosby Health](https://elion.health/products/crosby-health), [Protego Health](https://elion.health/products/protego-health), [SmarterDx SmarterDenials](https://elion.health/products/smarterdx-smarterdenials)

## **AI Agent Solutions**

When staffing is tight and follow-up tasks are dragging down productivity, AI agents offer a way to automate the repetitive, low-judgment work that still eats up time—especially for payers that don’t support fully digital workflows.

Leveraging large language models combined with voice and browser automation, these AI agents emulate the actions of a human billing specialist—such as logging into payer portals, managing lengthy hold times on phone calls, capturing detailed status updates—while still escalating tasks to human team members when the interaction exceeds their capabilities.

Most AI agents don’t operate standalone. They’re typically integrated into broader platforms or sold alongside complementary tools like intelligence dashboards or appeals automation systems. For example, [Adonis](https://elion.health/products/adonis-ai-agents) bundles its agents with its [Intelligence](https://elion.health/products/adonis-intelligence) product, while [Thoughtful AI](https://elion.health/products/thoughtful-ai) offers agents across multiple RCM use cases, not just denials.

These solutions are particularly useful for organizations with:

- High call volumes to payers

- Long hold times and staff burnout

- Enough process maturity to supervise and maintain a digital workforce

While AI agents won’t solve upstream denial causes or replace core appeals workflows, they are a powerful way to scale capacity to handle denials without scaling headcount.

**Products in this category include:** [Adonis AI Agents](https://elion.health/products/adonis-ai-agents), [Amperos Health](https://elion.health/products/amperos-health) “Amanda,” [Thoughtful AI](https://elion.health/products/thoughtful-ai) “DAN.”

## **Full-Stack RCM Suites with AI Denials Management Capabilities**

Health systems already using a [clearinghouse](https://elion.health/categories/claims-clearinghouse/products) or [full-suite RCM](https://elion.health/categories/claims-management/products) vendor often look first to what’s already available in their existing platform. In these cases, adding denials management as an incremental, integrated add-on can be faster, lower-risk, and easier to justify than layering on a new best-of-breed solution.

Unified revenue cycle platforms such as [Availity](https://elion.health/products/availity-essentials), [Optum](https://elion.health/products/optum-ar-and-denial-management), [Experian](https://elion.health/products/experian-denial-management), [Solventum](https://elion.health/products/solventum-360-encompass), and [Waystar](https://elion.health/products/waystar-denial-management) combine claim editing, payer connectivity, denial analytics, and increasingly sophisticated generative-AI appeal generation into a single cohesive suite.

This path is especially appealing for teams focused on vendor consolidation, limited by IT bandwidth, or trying to accelerate deployment timelines. On the other hand, while these platforms increasingly offer AI-driven capabilities, they may lag behind point solutions in terms of configurability or depth, particularly for complex denials or specialty workflows.

But for many organizations, the operational simplicity of a single vendor still outweighs the feature gaps, especially when speed, integration, and internal alignment matter most.

**Products in this category include:** [Availity](https://elion.health/products/availity-essentials), [Experian](https://elion.health/products/experian-denial-management), [Optum](https://elion.health/products/optum-ar-and-denial-management), [Solventum](https://elion.health/products/solventum-360-encompass), [Waystar](https://elion.health/products/waystar-denial-management).

## **EHR-Native Solutions**

For many providers, the simplest starting point is what’s already embedded in their [EHR](https://elion.health/categories/electronic-health-record-ehr/products). These native tools form the baseline tier of the market: available by default, with no new contracts or integrations required.

Leveraging built-in EHR capabilities provides a quick, minimally disruptive path to meaningful impact. The trade-off: When your needs advance toward predictive ML scoring, generative AI-driven appeals, or autonomous follow-up via payer portals and phone calls, you'll quickly encounter the limitations of your EHR's native toolset.

**Products in this category include:** [Epic](https://elion.health/products/epic), [Oracle Cerner](https://elion.health/products/oracle-cerner), [athenahealth](https://elion.health/products/athenahealth).

## **Overall Landscape**

The six groupings we’ve outlined should be viewed as reference points on a spectrum, rather than rigid silos. Most contemporary platforms straddle two or more zones, because denials management is a system‑level problem: Prevention, triage, follow‑up, and learning are tightly intertwined. Our breakdown highlights thecapability that drives a buyer’s initial business case, providing a practical lens for beginning comparison. When you evaluate vendors, look past labels and categorizations, and trace how each solution’s functions interlock with your existing workflows, data infrastructure, and staffing model.

Beyond the main categories, a number of emerging solutions orbit the denials space. For example, [Claimable](https://elion.health/products/claimable) enables patients to manage their own appeals—with provider oversight and support—via a shared dashboard that tracks status and facilitates documentation. Tools like this don’t replace core denials platforms, but they can complement them, especially for low-dollar, high-volume cases where patient engagement is strategically valuable.

As the landscape continues to evolve, keep an eye on these outliers. They may not fit neatly into traditional categories, but they could expand how your organization thinks about solving the denials problem.

# **Thinking about ROI**

For most health systems, the math around denials management is stark. In 2023, hospitals and health systems [spent](https://premierinc.com/newsroom/policy/claims-adjudication-costs-providers-257-billion-18-billion-is-potentially-unnecessary-expense) a total of $25.7 billion attempting to overturn denials. While shocking, this number represents an immense opportunity. Vendors we’ve spoken with consistently report that leading organizations effectively deploying AI-driven denials management solutions achieve an ROI of 3:1 or higher.

ROI flows through three core levers:

1. **Denial prevention:** AI-powered tools can reduce first-pass denial rates by 20-30%, thanks to real-time edits and predictive screening.

2. **Appeal success:** By generating higher-quality, data-informed appeals, platforms can lift success rates from 50-65% to 75%+.

3. **Operational efficiency:** Manual appeals cost up to $57 per case. Automation can cut that by more than half.

Take a mid-sized hospital with a 12% initial denial rate across 100,000 claims annually. That’s 12,000 denials and roughly $600,000 in processing costs alone, not including the denied revenue. AI platforms reduce both the volume of denials and the cost to resolve each one, while increasing recovery rates.

Building a business case starts with establishing your baseline metrics:

- Current denial rate and write-off amounts

- Appeal success rate and processing costs

- Staff FTEs dedicated to denials management

- Average days in A/R for denied claims

From there, model the impact across three time horizons:

- **Short-term**: Immediate gains from automating unworked or low-complexity appeals

- **Mid-term**: Improvements in first-pass denial rate and appeal success

- **Long-term**: Strategic gains from better payer negotiation, contract visibility, and workforce optimization

The investment typically includes software licensing, implementation costs, and change management support. While exact pricing varies by vendor and scope, many organizations target a payback period of 3-6 months. Regular monitoring of the key performance indicators outlined above (denial rates, appeal success, days in A/R, and cost per appeal) help ensure the solution delivers expected value while identifying opportunities for additional return.

Importantly, AI solutions ideally improve over time as the predictive models learn from your specific denial patterns and appeal outcomes. Organizations that take a long-term view, investing in proper implementation and staff training, often see ROI ratios climb in subsequent years. The key is viewing denials management not as a one-time fix, but as an evolving capability that continuously adapts to protect and maximize revenue.

# **Additional Denials Management Solution Considerations**

Now that the workflow, capabilities, vendor landscape, and ROI considerations have been established, how can provider organizations effectively evaluate available solutions to ensure the best fit?

This section highlights key factors for a rigorous evaluation. Since most organizations already have standardized criteria for cybersecurity, integration capabilities, and implementation support, the following questions primarily target denials management specifically. Given the emerging nature of AI, we've also included essential questions providers should ask regarding AI model performance, development practices, and governance.

Not every question will be relevant to all organizations or solutions, but collectively they offer a robust foundation for conducting a tailored and thorough evaluation.

## **Scope**

- Which types of claims and denials does the system prioritize or specialize in, if any?

- Does the system specialize in inpatient, outpatient, or both?

- Does it handle high-volume, low-complexity, or routine technical denials (e.g., missing modifiers, incorrect coding, eligibility issues)? Or, does it primarily handle complex denials like DRG downgrades, medical necessity denials, clinical validation disputes, readmission denials, or length of stay disputes?

## **Intelligence**

- Which components of the workflow are fully automated versus requiring manual intervention?

- For those requiring manual intervention, what amount of human time and effort is required?

- Which types of denials or scenarios _always_ require human intervention, such as cases involving nuanced clinical judgments, policy ambiguities, or appeals/escalations?

- For automation, are confidence scores used to route cases for human review versus automated actions, and can these thresholds be customized by the provider?

- For the confidence scores, what variables or formulas are used?

- Does it support direct submission of appeals to payer portals via RPA?

- Does it utilize voice AI agents to call payers?

- For triage, how does the solution rank or prioritize denials for follow-up? What variables are included?

- Does it employ predictive modeling to forecast denial likelihood before submission?

- Does the solution also review accepted claims for underpayment or general adherence to contractual terms?

- Does the solution use generative AI for tasks like appeal letter generation, clinical documentation analysis, and interpretation of denial explanations?

- What mechanisms are in place to help staff understand _why_ the model recommended a specific code or denial resolution (e.g., justification summaries, evidence linking, citation display, highlighted record sections)?

## **Commercial**

- What are the expected ROI metrics (e.g. denial reduction, overturn rate, time savings, recovered revenue, eliminated write-offs)?

- What data supports the ROI claims?

- What reductions in manual effort can be expected for billing staff, coders, and providers?

- What is the pricing structure (e.g., subscription, implementation fee, flat fee, per-patient-per-month, contingency/performance-based, shared savings)?

- Is a free trial or pilot program offered to validate performance before committing? What are the terms? Are there opt-out clauses tied to performance benchmarks?

## **AI Governance**

- For areas where generative AI is used, what strategies are employed to reduce the likelihood of hallucinations?

- Are the generative AI models custom-built for customers, generalized, or a combination thereof?

- What data sources are used to train the models (e.g., historical claims, remittance data, payer behavior, clinical documentation)?

- What is the policy on data ownership and how is data handled upon contract termination?

# **Final Thoughts**

AI-driven denials management is not a silver bullet, but it does represent a meaningful shift in how providers can approach one of the most persistent challenges in the revenue cycle. While solutions vary in their capabilities and workflow alignment, the emergence of automation, predictive modeling, and generative AI opens the door to new levels of efficiency and recoverability.

For provider organizations, the key is not just whether a solution uses AI, but how that intelligence is applied: Does it support staff or replace key judgment calls? Can it integrate seamlessly into existing workflows? Is performance measurable, explainable, and aligned with operational realities?

If denials are a growing pain point, it’s worth investigating whether modern AI tools can relieve pressure or improve recovery. Use the evaluation criteria in this guide to define your requirements, stress-test vendor claims, and determine whether these solutions merit a pilot, investment, or continued monitoring. And as always, our team is happy to help you work through your options. [Fill out this form](https://docs.google.com/forms/d/e/1FAIpQLSeG1rTWpp9kuYZhNitEHkbcz2bGngiplvMQ-3q57Tv6VDeFuw/viewform?usp=header) to connect with our team.

---
*Source: [Elion Health](https://elion.health/resources/ai-denials-management-buyers-guide)*